Medical devices have been receiving more public attention and scrutiny in recent years because of safety problems. A 2018 Netflix documentary, The Bleeding Edge, highlighted multiple such medical devices, 2 of which, Essure (a device for female sterilization) and transvaginal mesh for pelvic organ prolapse, were taken off the market after the film’s release. Recent Kaiser Health News stories reported that more than 1 million medical device adverse event reports had been sealed from public view by the US Food and Drug Administration (FDA).1The New York Times recently called for reforms in device regulation in an editorial entitled “80,000 Deaths. 2 Million Injuries. It’s Time for a Reckoning on Medical Devices.”2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Redberg RF, Dhruva SS. Moving From Substantial Equivalence to Substantial Improvement for 510(k) Devices. JAMA. Published online July 29, 2019322(10):927–928. doi:10.1001/jama.2019.10191
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: